Form 4 Filing for Atea Pharmaceuticals, Inc.

Polly A. Murphy, a director at Atea Pharmaceuticals, Inc. (AVIR), reported several transactions on June 18, 2026. Murphy acquired 29,600 shares of Common Stock, increasing her total holdings to 121,745 shares. Concurrently, she disposed of 29,600 Restricted Stock Units (RSUs) which vested on the same date. Additionally, Murphy was granted 26,700 RSUs and received 37,700 Stock Options, both with a $0.00 price per share. The RSUs vest based on continued service, with full vesting by June 18, 2027. The stock options also vest in monthly installments over the same period. These transactions were filed on Form 4, signed by Andrea Corcoran as attorney-in-fact for Polly A. Murphy on June 23, 2026.